UPDATE 1-Ariad suspends sales of blood cancer drug, shares sink

Oct 31 (Reuters) - Ariad Pharmaceuticals Inc said it would suspend sales of its blood cancer drug Iclusig, barely two weeks after it stopped an ongoing trial of the drug due to safety concerns.

from Reuters: Hot Stocks http://feeds.reuters.com/~r/reuters/hotStocksNews/~3/Uzri4fMpDsE/story01.htm